Sounds pretty feasible to me- they requested raw data not to delay decision making but to speed up EUA for CYDY. Data is expected within this week to next week as well as what was said in the divisions. I would think CYDY would let shareholders know how many vials each country has secured will be PR. Think of how vaccines will have a meeting in which within I think two days later they granted EUA. If they needed 2-3 weeks for life saving mortality reducing limited supply therapeutic its a much bigger deal than any vaccine and I can see the biggest delay coming from deciding exactly what patients and at what stage to give leronlimab to covid patients- when mild severe moderate severe or critical. I’m sure future manufacturing is in the confidential discussions and pricing. I would think the 28 day mortality 42 and 60 day are easily accessible to the FDA all three health regulators and CYDY. I don’t think we need to see anything more than a 20-25% reduction of mortality at day 28 for EUA I think we will be closer to 35-40% I think CYDY mortality reduction will be higher at day 42 ans day 60 possible 50% mortality reduction good enough for full approval. I think that CYDY in 3 different confidential talks as opposed to all 3 countries health officials sitting at same table. I think that there will be much more of a sense of urgency for purchase contracts and EUA being granted as there is very high worldwide demand for a SAFE mortality reducing easily administered through a shot therapeutic. There isn’t any drug in the world to make it through phase 3 with mortality as primary endpoint and not have modifications or has to enroll additional patients and was
Actually recommended do a 75% look in but we finished trial 100% ensuring best chances at full approval. I’m really excited for this coming week as PR drop increases like a winter storm you know is coming straight for you but it not a watch until several days away when couple days out and than it turns into warming and than BAM perfect storm hits of Great cd-12 data results - billions in contracted sales - Nasdaq uplist- long haulers I believe first approved Long Haulers study